Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160563PMC
http://dx.doi.org/10.2337/ds21-0025DOI Listing

Publication Analysis

Top Keywords

probable dapagliflozin-associated
4
dapagliflozin-associated acute
4
acute pancreatitis
4
probable
1
acute
1
pancreatitis
1

Similar Publications

Background: There is limited evidence on the safety of sodium-glucose co-transporter-2 inhibitor (SGLT2i) use in the real world of China. We conducted this two-center, retrospective study to assess the incidence rate and risk factors of Dapagliflozin-associated DK/DKA among patients with type 2 diabetes mellitus (T2DM) in China.

Research Design And Methods: Patients with T2DM treated with Dapagliflozin in Shanghai General Hospital were included in this retrospective analysis.

View Article and Find Full Text PDF

Objective: To investigate the risk factors of dapagliflozin-associated diabetic ketosis/ketoacidosis (DK/DKA) in patients with type 2 diabetes mellitus (T2DM).

Research Design And Methods: A case-control study was conducted in a general hospital in China from 2018 to 2021. T2DM patients who developed DK/DKA after dapagliflozin treatment were identified.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!